126 related articles for article (PubMed ID: 7371346)
21. The bone scan in thyroid cancer.
Dewan SS
J Nucl Med; 1979 Mar; 20(3):271-2. PubMed ID: 24180059
[No Abstract] [Full Text] [Related]
22. Radioiodine uptake by metastatic nonthyroidal adenocarcinoma of the lung in a patient with papillary thyroid carcinoma.
Sohn MH; Kim MW; Lim ST; Lee NR; Song EK; Yim CY
Clin Nucl Med; 2005 Apr; 30(4):269-70. PubMed ID: 15764888
[TBL] [Abstract][Full Text] [Related]
23. Intense Tl-201 uptake in a "cold" bone lesion due to metastatic thyroid carcinoma.
Valdés Olmos RA; Hoefnagel CA; Delprat CC
Clin Nucl Med; 1990 Oct; 15(10):735-7. PubMed ID: 2225682
[No Abstract] [Full Text] [Related]
24. Minimal bone scan findings in the presence of wide-spread osteoblastic disease on skeletal radiography.
Silberstein EB; Schroder LE
Clin Nucl Med; 1990 Nov; 15(11):816-7. PubMed ID: 2292155
[TBL] [Abstract][Full Text] [Related]
25. Value of routine radionuclide bone scans in renal cell carcinoma.
Blacher E; Johnson DE; Haynie TP
Urology; 1985 Nov; 26(5):432-4. PubMed ID: 4060382
[TBL] [Abstract][Full Text] [Related]
26. [A case report of thyroid papillary cancer that manifested leukocytosis and hypercalcemia after radiotherapy in bone metastasis].
Kobayashi H; Endo K; Nishimura K; Kasagi K; Yamamoto I; Konishi J; Abe M; Shimizu Y
Gan No Rinsho; 1989 Jan; 35(1):55-62. PubMed ID: 2646465
[TBL] [Abstract][Full Text] [Related]
27. [The early scintigraphic diagnosis of bone metastases in prostatic carcinoma].
Petrov T; Tsvetkov M; Mladenov D; Kumanov Kh
Khirurgiia (Sofiia); 1991; 44(5):28-9. PubMed ID: 1844461
[TBL] [Abstract][Full Text] [Related]
28. Differentiated thyroid carcinoma: Incremental diagnostic value of
Zilioli V; Peli A; Panarotto MB; Magri G; Alkraisheh A; Wiefels C; Rodella C; Giubbini R
Endocrine; 2017 Jun; 56(3):551-559. PubMed ID: 27709475
[TBL] [Abstract][Full Text] [Related]
29. Radionuclide bone scan, radiographic bone survey, and alkaline phosphatase: studies of limited value in asymptomatic patients with ovarian carcinoma.
Mettler FA; Christie JH; Crow NE; Garcia JF; Wicks JD; Bartow SA
Cancer; 1982 Oct; 50(8):1483-5. PubMed ID: 6288213
[TBL] [Abstract][Full Text] [Related]
30. False-positive radioiodine whole-body scan in thyroid cancer patients due to unrelated pathology.
Bakheet SM; Hammami MM
Clin Nucl Med; 1994 Apr; 19(4):325-9. PubMed ID: 8004865
[TBL] [Abstract][Full Text] [Related]
31. Bony expansion in skeletal metastases from carcinoma of the prostate as seen by bone scintigraphy.
Resnik CS; Garver P; Resnick D
South Med J; 1984 Oct; 77(10):1331-5. PubMed ID: 6484659
[TBL] [Abstract][Full Text] [Related]
32. Tc-99m-pertechnetate scanning in metastatic thyroid carcinoma: a case report.
Lamberigts G; De Roo M; Devos P; Burie D
Clin Nucl Med; 1981 Apr; 6(4):172-4. PubMed ID: 7214773
[TBL] [Abstract][Full Text] [Related]
33. Long-term outcome of 444 patients with distant metastases from papillary and follicular thyroid carcinoma: benefits and limits of radioiodine therapy.
Durante C; Haddy N; Baudin E; Leboulleux S; Hartl D; Travagli JP; Caillou B; Ricard M; Lumbroso JD; De Vathaire F; Schlumberger M
J Clin Endocrinol Metab; 2006 Aug; 91(8):2892-9. PubMed ID: 16684830
[TBL] [Abstract][Full Text] [Related]
34. The usefulness of iodine-123 whole-body scans in evaluating thyroid carcinoma and metastases.
Yaakob W; Gordon L; Spicer KM; Nitke SJ
J Nucl Med Technol; 1999 Dec; 27(4):279-81. PubMed ID: 10646545
[TBL] [Abstract][Full Text] [Related]
35. Radioiodine I-131 therapy in the management of differentiated thyroid carcinoma: a review of 202 patients.
Chen WL; Guan SI; Huang WS
J Formos Med Assoc; 1993 Jul; 92(7):623-31. PubMed ID: 7904498
[TBL] [Abstract][Full Text] [Related]
36. Lung metastases in patients with differentiated thyroid carcinoma and evaluation of response to radioiodine therapy.
Kalender E; Zeki Celen Y; Elboga U; Deniz Demir H; Yilmaz M
Rev Esp Med Nucl Imagen Mol; 2012; 31(6):328-31. PubMed ID: 23084016
[TBL] [Abstract][Full Text] [Related]
37. Value of thyroid carcinoma imaging after therapeutic doses of radioiodine.
Balachandran S; Sayle BA
Clin Nucl Med; 1981 Apr; 6(4):162-7. PubMed ID: 7214771
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of technetium-99m-MIBI scintigraphy in metastatic differentiated thyroid carcinoma.
Miyamoto S; Kasagi K; Misaki T; Alam MS; Konishi J
J Nucl Med; 1997 Mar; 38(3):352-6. PubMed ID: 9074516
[TBL] [Abstract][Full Text] [Related]
39. Insensitivity of Tc-99m pertechnetate for detecting metastases of differentiated thyroid carcinoma.
Campbell CM; Khafagi FA
Clin Nucl Med; 1990 Jan; 15(1):1-4. PubMed ID: 2155079
[TBL] [Abstract][Full Text] [Related]
40. Abnormal uptake in the sacrum on bone scan.
Ackerman L; Shirazi P; Van Drunen M
Semin Nucl Med; 2000 Jan; 30(1):67-9. PubMed ID: 10656246
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
